Back to Journals » Drug Design, Development and Therapy » Volume 7

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]

Authors Mazo DFDC, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP

Received 24 July 2013

Accepted for publication 24 July 2013

Published 13 September 2013 Volume 2013:7 Pages 971—972

DOI https://doi.org/10.2147/DDDT.S52000


Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563.

On page 554, the sentence "Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treating fibrosis..." contains an error. The term "antifibrinogenic" should be replaced by "antifibrogenic".
On page 558, Figure 3 (D), the intermediate block corresponding to SNAC is missing.

View original paper by Mazo et al

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]